IC
Ikarian Capital Portfolio holdings
AUM
$302M
This Quarter Return
+17.81%
1 Year Return
+65.21%
3 Year Return
+441.33%
5 Year Return
+548.26%
10 Year Return
–
AUM
$200M
AUM Growth
+$200M
(-17%)
Cap. Flow
-$68M
Cap. Flow
% of AUM
-33.93%
Top 10 Holdings %
Top 10 Hldgs %
50.04%
Holding
142
New
18
Increased
7
Reduced
40
Closed
52
Top Buys
Top Sells
| 1 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$12.7M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$11.7M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$11.3M |
| 4 |
United Therapeutics
UTHR
|
$9.43M |
| 5 |
Celldex Therapeutics
CLDX
|
$6.2M |
Sector Composition
| 1 | Healthcare | 98.33% |
| 2 | Consumer Staples | 0% |
| 3 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ISEE
1
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $17.6M | 3.5% | 978,783 +929,684 | +1,893% | +$16.7M |
|
2
Esperion Therapeutics
ESPR
$448M
| $14.3M | 2.85% | 2,131,147 +76,545 | +4% | +$513K |
|
|
RXDX
3
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $13.6M | 2.72% | +231,181 | New | +$13.6M |
|
|
DCPH
4
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $9.11M | 1.81% | +492,275 | New | +$9.11M |
|
|
BLU
5
DELISTED
BELLUS Health Inc.
BLU
| $8.98M | 1.79% | 850,134 -168,193 | -17% | -$1.78M |
|
|
6
Celldex Therapeutics
CLDX
$1.47B
| $8.92M | 1.78% | 317,476 -220,482 | -41% | -$6.2M |
|
7
Milestone Pharmaceuticals
MIST
$156M
| $7.86M | 1.57% | 855,616 -523,806 | -38% | -$4.81M |
|
8
Gossamer Bio
GOSS
$562M
| $7.31M | 1.46% | 610,407 -389,980 | -39% | -$4.67M |
|
9
Astria Therapeutics
ATXS
$349M
| $6.32M | 1.26% | 699,440 +107,317 | +18% | +$970K |
|
10
Kezar Life Sciences
KZR
$28.9M
| $6.27M | 1.25% | 728,586 -679,530 | -48% | -$5.85M |
|
|
SAGE
11
DELISTED
Sage Therapeutics
SAGE
| $6.18M | 1.23% | +157,805 | New | +$6.18M |
|
12
Altimmune
ALT
$338M
| $6.03M | 1.2% | 472,054 -425,305 | -47% | -$5.43M |
|
13
Xenon Pharmaceuticals
XENE
$2.98B
| $5.79M | 1.15% | 160,486 -78,955 | -33% | -$2.85M |
|
14
Terns Pharmaceuticals
TERN
$609M
| $5.33M | 1.06% | 904,119 +204,119 | +29% | +$1.2M |
|
15
Acadia Pharmaceuticals
ACAD
$4.38B
| $5.32M | 1.06% | +325,000 | New | +$5.32M |
|
|
CERE
16
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $5.03M | 1% | +178,100 | New | +$5.03M |
|
|
TCON
17
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
| $4.62M | 0.92% | 2,765,530 -23,323 | -0.8% | -$38.9K |
|
|
HZNP
18
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $4.59M | 0.92% | 74,219 -85,897 | -54% | -$5.32M |
|
19
Immunovant
IMVT
$2.56B
| $4.53M | 0.9% | +811,700 | New | +$4.53M |
|
20
Ardelyx
ARDX
$1.53B
| $3.78M | 0.75% | 3,178,825 +1,498,273 | +89% | +$1.78M |
|
21
Acumen Pharmaceuticals
ABOS
$82.4M
| $3.51M | 0.7% | +350,000 | New | +$3.51M |
|
|
PNT
22
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $3.48M | 0.69% | +450,406 | New | +$3.48M |
|
|
JBIO
23
Jade Biosciences, Inc. Common Stock
JBIO
$258M
| $3.32M | 0.66% | +200,000 | New | +$3.32M |
|
24
ARK Genomic Revolution ETF
ARKG
$1.04B
| $3.17M | 0.63% | +96,462 | New | +$3.17M |
|
25
scPharmaceuticals
SCPH
$295M
| $3.13M | 0.62% | 479,383 -404,625 | -46% | -$2.64M |
|